1. Home
  2. TORO vs BDSX Comparison

TORO vs BDSX Comparison

Compare TORO & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Toro Corp.

TORO

Toro Corp.

HOLD

Current Price

$5.33

Market Cap

154.9M

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$14.87

Market Cap

143.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TORO
BDSX
Founded
2022
2005
Country
Cyprus
United States
Employees
N/A
N/A
Industry
Marine Transportation
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
154.9M
143.2M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
TORO
BDSX
Price
$5.33
$14.87
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$32.50
AVG Volume (30 Days)
248.4K
67.6K
Earning Date
04-15-2026
05-04-2026
Dividend Yield
36.86%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$88,499,000.00
Revenue This Year
N/A
$25.26
Revenue Next Year
N/A
$19.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.08
52 Week Low
$1.81
$0.26
52 Week High
$8.50
$20.21

Technical Indicators

Market Signals
Indicator
TORO
BDSX
Relative Strength Index (RSI) 48.95 56.29
Support Level $5.06 $13.46
Resistance Level $5.94 $16.38
Average True Range (ATR) 0.49 1.09
MACD -0.13 0.11
Stochastic Oscillator 17.33 48.74

Price Performance

Historical Comparison
TORO
BDSX

About TORO Toro Corp.

Toro Corp is engaged in the acquisition, ownership, chartering, and operation of oceangoing tanker and LPG carrier vessels, providing seaborne transportation services for crude oil, refined petroleum products, and liquefied petroleum gas. The company operates through three segments: the Eco tanker segment, the Non-Eco tanker segment, and the LPG carrier segment. It generates the majority of its revenue from the LPG carrier segment.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Share on Social Networks: